Exploring the possible relationship between the drug release of Compritol®-containing tablets and its polymorph forms using micro X-ray diffraction
Authors:
- 1 January 2015
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 197, 158-164
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Solid lipid excipients — Matrix agents for sustained drug deliveryJournal of Controlled Release, 2014
- Polyoxylglycerides and glycerides: Effects of manufacturing parameters on API stability, excipient functionality and processingInternational Journal of Pharmaceutics, 2014
- Innovation of novel ‘Tab in Tab’ system for release modulation of milnacipran HCl: optimization, formulation and in vitro investigationsDrug Development and Industrial Pharmacy, 2012
- Development and evaluation of sustained-release Compritol®888 ATO matrix mini-tabletsDrug Development and Industrial Pharmacy, 2011
- Innovation of novel sustained release compression-coated tablets for lornoxicam: formulation and in vitro investigationsDrug Development and Industrial Pharmacy, 2010
- Controlled-Release Carbamazepine Granules and Tablets Comprising Lipophilic and Hydrophilic Matrix ComponentsAAPS PharmSciTech, 2008
- Approaches for the development of solid and semi-solid lipid-based formulationsAdvanced Drug Delivery Reviews, 2008
- In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tabletsInternational Journal of Pharmaceutics, 2006
- Evaluation and Comparison of Five Matrix Excipients for the Controlled Release of Acrivastine and PseudoephedrineDrug Development and Industrial Pharmacy, 2004
- Controlled release of tramadol hydrochloride from matrices prepared using glyceryl behenateEuropean Journal of Pharmaceutics and Biopharmaceutics, 2001